Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VH4524184 Monotherapy in Treatment-Naïve HIV-1
NCT06214052Phase 2Completed
- Sponsor
- ViiV Healthcare
- Start
- Feb 2024
- Primary completion
- Jun 2024
- Modality
- Small Molecules
- Countries
- 5
01
Overview
A Phase 2 trial of VH4524184 in human immunodeficiency virus type 1 infection (HIV-1), sponsored by ViiV Healthcare. Started Feb 2024; status: completed.
02
Drugs
VH4524184
03
Conditions
human immunodeficiency virus type 1 infection (HIV-1)
Beyond the preview
Go deeper on NCT06214052.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06214052.